Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-17 Sale |
2022-08-19 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $165.24 | $1,652,400 | 15,333,952 (Indirect Direct) |
View |
| 2022-08-10 Sale |
2022-08-12 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $174.09 | $1,740,900 | 15,343,952 (Indirect Direct) |
View |
| 2022-08-03 Sale |
2022-08-05 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $167.99 | $1,679,900 | 15,353,952 (Indirect Direct) |
View |
| 2022-07-27 Sale |
2022-07-29 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $161 | $1,610,000 | 15,363,952 (Indirect Direct) |
View |
| 2022-07-20 Sale |
2022-07-22 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $167 | $1,670,000 | 15,373,952 (Indirect Direct) |
View |
| 2022-07-13 Sale |
2022-07-15 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $168.88 | $1,688,800 | 15,383,952 (Indirect Direct) |
View |
| 2022-07-13 Sale |
2022-07-15 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $168.88 | $1,688,800 | 15,383,952 (Indirect Direct) |
View |
| 2022-07-06 Sale |
2022-07-08 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $154.85 | $1,548,500 | 15,393,952 (Indirect Direct) |
View |
| 2022-07-05 Purchase |
2022-07-07 5:00 pm |
Seres Therapeutics Inc. | MCRB | Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
8,738,243 | $3.15 | $27,525,465 | 17,617,352 (Indirect) |
View |
| 2022-06-29 Sale |
2022-07-01 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $140.47 | $1,404,700 | 15,403,952 (Indirect Direct) |
View |
| 2022-06-22 Sale |
2022-06-24 7:42 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $127.69 | $1,276,900 | 15,413,952 (Indirect Direct) |
View |
| 2022-06-08 Sale |
2022-06-10 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $147.47 | $1,474,700 | 15,423,952 (Indirect Direct) |
View |
| 2022-06-01 Sale |
2022-06-03 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $146.31 | $1,463,100 | 15,433,952 (Indirect Direct) |
View |
| 2022-05-27 Purchase |
2022-06-01 7:00 pm |
Evelo Biosciences Inc. | EVLO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
27,397,259 | $1.46 | $39,999,998 | 27,233,921 (Indirect) |
View |
| 2022-05-25 Sale |
2022-05-27 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $130.8 | $1,308,000 | 15,443,952 (Indirect Direct) |
View |
| 2022-05-18 Sale |
2022-05-20 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $138.38 | $1,383,800 | 15,453,952 (Indirect Direct) |
View |
| 2022-05-11 Sale |
2022-05-13 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
310,000 | $131.79 | $40,855,186 | 19,510,689 (Indirect Direct) |
View |
| 2022-03-16 Purchase |
2022-03-18 08:30 am |
Axcella Health Inc. | AXLA | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner |
6,319,371 | $1.91 | $12,069,999 | 8,262,725 (Indirect) |
View |
| 2021-08-03 Purchase |
2021-08-05 5:41 pm |
Omega Therapeutics Inc. | OMGA | Flagship Pioneering Inc. Flagship Pioneering Fund VI General Partner LLC Flagship Pioneering Fund VI L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Special Opportunities Fund II General Partner LLC Nutritional Health LTP Fund L.P. Nutritional Health LTP Fund General Partner LLC FPN General Partner LLC FPN L.P. AFEYAN NOUBAR 10% Owner |
1,176,469 | $17 | $19,999,973 | 3,814,705 (Indirect) |
View |
| 2021-03-29 Sale |
2021-03-31 8:00 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
3,752,805 | $121.43 | $455,692,554 | 22,682,719 (Indirect Direct) |
View |
| 2021-03-19 Purchase |
2021-03-23 5:30 pm |
Rubius Therapeutics Inc. | RUBY | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner |
210,000 | $29 | $6,090,000 | 17,253,519 (Indirect) |
View |
| 2021-02-24 Sale |
2021-02-24 8:31 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
1,753,697 | $146.19 | $256,378,924 | 26,435,524 (Indirect Direct) |
View |
| 2021-02-22 Sale |
2021-02-24 8:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
4,784,404 | $152.59 | $730,069,590 | 28,189,221 (Indirect Direct) |
View |
| 2021-02-08 Purchase |
2021-02-10 5:30 pm |
Kaleido Biosciences Inc. | KLDO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. AFEYAN NOUBAR 10% Owner |
215,000 | $11.5 | $2,472,500 | 14,907,627 (Indirect) |
View |
| 2021-02-02 Purchase |
2021-02-04 5:56 pm |
Evelo Biosciences Inc. | EVLO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. AFEYAN NOUBAR 10% Owner |
130,000 | $15 | $1,950,000 | 17,660,752 (Indirect) |
View |
| 2020-10-27 Purchase |
2020-10-29 4:58 pm |
Foghorn Therapeutics Inc. | FHTX | Flagship Ventures Fund V General Partner LLC Flagship Ventures Opportunities Fund I General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
150,000 | $16 | $2,400,000 | 1,851,801 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion